It was approved by the FDA in 2022 for adults with obesity and those who have overweight with at least one weight-related condition, like type 2 diabetes or high blood pressure
Mounjaro Mounjaro, with the active ingredient tirzepatide, regulates blood sugar, reduces appetite, and curbs cravings
November 2024: Pulmonary aspiration during general anesthesia or deep sedation was added
The approval for manufacturing and marketing the drug for both type 2 diabetes and obesity indications was granted earlier by the Drugs Controller General of India (DCGI)
Custom notes for hot flashes, sleep disruption, cravings, cycle changes, or mood shifts you want to watch over time
How much protein should I eat at breakfast on semaglutide